Ernst J. Wolvetang < Erwan Bezard < Erwan Bézard

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 61.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000062 (2016)	Anna Migdalska-Richards ; Liam Daly ; Erwan Bezard ; Anthony H V. Schapira	Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
000068 (2016)	Wai Kin D. Ko ; Sandrine M. Camus ; Qin Li ; Jianzhong Yang ; Steve Mcguire ; Elsa Y. Pioli ; Erwan Bezard	An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models.
000082 (2016)	Michel Engeln ; Solène Ansquer ; Emilie Dugast ; Erwan Bezard ; David Belin ; Pierre-Olivier Fernagut	Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy.
000095 (2016)	François Tison ; Charlotte Keywood ; Mark Wakefield ; Franck Durif ; Jean-Christophe Corvol ; Karla Eggert ; Mark Lew ; Stuart Isaacson ; Erwan Bezard ; Sonia-Maria Poli ; Christopher G. Goetz ; Claudia Trenkwalder ; Olivier Rascol	A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease.
000137 (2016)	Benjamin Dehay ; Mickael Decressac ; Mathieu Bourdenx ; Irene Guadagnino ; Pierre-Olivier Fernagut ; Anna Tamburrino ; Fares Bassil ; Wassilios G. Meissner ; Erwan Bezard	Targeting α-synuclein: Therapeutic options.
000139 (2016)	Thibaud Thiollier ; Caisheng Wu ; Hugues Contamin ; Qin Li ; Jinlan Zhang ; Erwan Bezard	Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.
000151 (2016)	Ludovico Arcuri ; Riccardo Viaro ; Simone Bido ; Francesco Longo ; Mariangela Calcagno ; Pierre-Olivier Fernagut ; Nurulain T. Zaveri ; Girolamo Cal ; Erwan Bezard ; Michele Morari	Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease.
000170 (2016)	Annalisa Pinna ; Wai Kin D. Ko ; Giulia Costa ; Elisabetta Tronci ; Camino Fidalgo ; Nicola Simola ; Qin Li ; Mojgan Aghazadeh Tabrizi ; Erwan Bezard ; Manolo Carta ; Micaela Morelli	Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease.
000180 (2016)	Michel Engeln ; Matthieu F. Bastide ; Estelle Toulmé ; Benjamin Dehay ; Mathieu Bourdenx ; Evelyne Doudnikoff ; Qin Li ; Christian E. Gross ; Eric Boué-Grabot ; Antonio Pisani ; Erwan Bezard ; Pierre-Olivier Fernagut	Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia.
000188 (2016)	Mathieu Schmitt ; Benjamin Dehay ; Erwan Bezard ; F Javier Garcia-Ladona	Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line.
000196 (2016)	Benjamin Dehay ; Miquel Vila ; Erwan Bezard ; Patrik Brundin ; Jeffrey H. Kordower	Alpha-synuclein propagation: New insights from animal models.
000200 (2016)	Sandra Dovero ; Christian Gross ; Erwan Bezard	Unexpected toxicity of very low dose MPTP in mice: A clue to the etiology of Parkinson's disease?
000212 (2016)	Mathieu Bourdenx ; Jonathan Daniel ; Emilie Genin ; Federico N. Soria ; Mireille Blanchard-Desce ; Erwan Bezard ; Benjamin Dehay	Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases.
000289 (2015)	Sandrine Camus ; Wai Kin D. Ko ; Elsa Pioli ; Erwan Bezard	Why bother using non-human primate models of cognitive disorders in translational research?
000301 (2015)	Michel Engeln ; Philippe De Deurwaerdère ; Qin Li ; Erwan Bezard ; Pierre-Olivier Fernagut	Widespread Monoaminergic Dysregulation of Both Motor and Non-Motor Circuits in Parkinsonism and Dyskinesia.
000317 (2015)	Benjamin Dehay ; Mathieu Bourdenx ; Philippe Gorry ; Serge Przedborski ; Miquel Vila ; Stéphane Hunot ; Andrew Singleton ; C Warren Olanow ; Kalpana M. Merchant ; Erwan Bezard ; Gregory A. Petsko ; Wassilios G. Meissner	Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations.
000324 (2015)	Mathieu Bourdenx ; Nikolaos Stavros Koulakiotis ; Despina Sanoudou ; Erwan Bezard ; Benjamin Dehay ; Anthony Tsarbopoulos	Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
000354 (2015)	Nikhil M. Urs ; Simone Bido ; Sean M. Peterson ; Tanya L. Daigle ; Caroline E. Bass ; Raul R. Gainetdinov ; Erwan Bezard ; Marc G. Caron	Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.
000370 (2015)	Erwan Bezard ; Manolo Carta	Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson's disease?
000501 (2014)	Mathieu Bourdenx ; Benjamin Dehay ; Erwan Bezard	Down-regulating α-synuclein for treating synucleopathies.
000504 (2014)	Wai Kin D. Ko ; Marie-Laure Martin-Negrier ; Erwan Bezard ; Alan R. Crossman ; Paula Ravenscroft	RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/Author.i -k "Erwan Bezard" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/Author.i  \
                -Sk "Erwan Bezard" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    Author.i
   |clé=    Erwan Bezard
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024